The article offers information on a gastroenterology conference which involved panel discussion with four hepatologists as co-panellists and other members. Topics discussed include use of generic drugs for treatment of hepatitis C virus (HCV) in India; information regarding treatment of the patients with HCV using sofosbuvir and daclatasvir; and need for organizing informative continuing medical education (CME).